簡介

本頁面提供了有關 Daniel Lee Flynn 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Daniel Lee Flynn已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:DCPH / Deciphera Pharmaceuticals, Inc. Chief Scientific Officer 57,158
如何解讀這些圖表

以下圖表顯示了在Daniel Lee Flynn進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Daniel Lee Flynn 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2023-06-21 2023-06-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -1,655 57,158 -2.81 14.40 -23,835 823,178
2023-02-17 2023-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -1,370 58,813 -2.28 15.10 -20,686 888,017
2023-02-17 2023-02-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 16,488 60,183 37.73
2023-01-19 2023-01-17 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2,403 43,695 -5.21 21.24 -51,043 928,139
2022-06-21 2022-06-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -1,768 46,098 -3.69 10.75 -19,006 495,554
2022-02-18 2022-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -1,366 47,866 -2.77 9.05 -12,362 433,187
2022-01-20 2022-01-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 82,000 82,000
2022-01-20 2022-01-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 20,500 49,232 71.35
2021-12-17 2021-12-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 82,265 82,265
2021-12-17 2021-12-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 11,100 28,732 62.95
2021-02-18 2021-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 49,900 49,900
2021-02-18 2021-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 11,100 17,632 169.93
2021-02-18 2021-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -508 6,532 -7.22 48.87 -24,826 319,219
2020-08-12 2020-08-10 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -9,029 0 -100.00
2020-08-12 2020-08-10 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 9,029 237,475 3.95 1.89 17,065 448,828
2020-07-24 2020-07-22 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -130,000 9,029 -93.51
2020-07-24 2020-07-22 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 130,000 228,446 132.05 1.89 245,700 431,763
2020-02-20 2020-02-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award -42,190 42,190 -50.00
2020-02-20 2020-02-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 7,040 98,446 7.70
2020-01-22 2020-01-16 4/A DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -10,106 4,944 -67.15
2020-01-21 2020-01-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -56,800 94,817 -37.46
2020-01-21 2020-01-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -10,106 29,444 -25.55
2020-01-21 2020-01-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 56,800 91,406 164.13 6.13 348,184 560,319
2020-01-21 2020-01-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 10,106 34,606 41.25 3.95 39,919 136,694
2019-12-13 2019-12-12 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -31,029 35,750 -46.47 60.00 -1,861,740 2,145,000
2019-12-11 2019-12-10 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -93,930 13,897 -87.11
2019-12-11 2019-12-10 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -28,822 107,827 -21.09
2019-12-11 2019-12-10 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -93,930 24,500 -79.31 55.00 -5,166,150 1,347,500
2019-12-11 2019-12-10 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 93,930 118,430 383.39 1.89 177,528 223,833
2019-12-11 2019-12-10 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -28,822 24,500 -54.05 55.00 -1,585,210 1,347,500
2019-12-11 2019-12-10 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 28,822 53,322 117.64 1.89 54,474 100,779
2019-12-11 2019-12-09 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -30,175 136,649 -18.09
2019-12-11 2019-12-09 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -30,175 24,500 -55.19 55.00 -1,659,625 1,347,500
2019-12-11 2019-12-09 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 30,175 54,675 123.16 1.89 57,031 103,336
2019-11-13 2019-11-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -143,185 166,824 -46.19
2019-11-13 2019-11-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -143,185 24,500 -85.39 48.01 -6,874,870 1,176,341
2019-11-13 2019-11-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 143,185 167,685 584.43 1.89 270,620 316,925
2019-11-13 2019-11-08 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -9,742 310,009 -3.05
2019-11-13 2019-11-08 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -9,742 24,500 -28.45 48.00 -467,616 1,176,000
2019-11-13 2019-11-08 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 9,742 34,242 39.76 1.89 18,412 64,717
2019-10-30 2019-10-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -29,820 319,751 -8.53
2019-10-30 2019-10-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -29,820 24,500 -54.90 40.00 -1,192,800 980,000
2019-10-30 2019-10-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 29,820 54,320 121.71 1.89 56,360 102,665
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -123,107 349,571 -26.04
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -25,000 66,779 -27.24 42.90 -1,072,500 2,864,819
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -29,712 24,500 -54.81 41.33 -1,227,911 1,012,514
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -93,395 54,212 -63.27 40.26 -3,760,344 2,182,727
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 123,107 147,607 502.48 1.89 232,672 278,977
2019-03-20 2017-08-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
G - Gift 55,270 147,049 60.22
2019-03-20 2017-08-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
G - Gift -55,270 0 -100.00
2019-02-25 2019-02-21 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -24,500 15,050 -61.95
2019-02-25 2019-02-21 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 24,500 24,500 3.95 96,775 96,775
2019-02-01 2019-01-30 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 75,000 75,000
2019-01-18 2019-01-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -152,629 472,678 -24.41
2019-01-18 2019-01-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -152,629 0 -100.00 26.00 -3,968,354
2019-01-18 2019-01-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 152,629 152,629 1.89 288,469 288,469
2019-01-18 2018-03-23 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
G - Gift -91,779 55,270 -62.41
2019-01-18 2018-03-23 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
G - Gift 91,779 91,779
2019-01-15 2019-01-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -300 625,307 -0.05
2019-01-15 2019-01-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -300 0 -100.00 26.00 -7,800
2019-01-15 2019-01-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 300 300 1.89 567 567
2018-09-20 2018-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 68,500 68,500
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise 151,617 151,617
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -26,835 0 -100.00
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise 39,550 39,550
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -7,000 0 -100.00
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise 139,029 139,029
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -24,607 0 -100.00
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise 625,607 625,607
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -110,727 0 -100.00
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Series C Preferred Stock
C - Conversion -1,071 0 -100.00
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Series B-2 Preferred Stock
C - Conversion -1,392 0 -100.00
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Series B-1 Preferred Stock
C - Conversion -1,494 0 -100.00
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Series A Preferred Stock
C - Conversion -22,070 0 -100.00
2018-09-20 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
C - Conversion 147,049 147,049
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)